Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Autran

Showing results (31-40 of 201) with videos related to

Pageof 21
Sort By:
Experimental Gerontology|February 20, 2007
Accelerated immune senescence and HIV-1 infectionVictor Appay, Jorge R Almeida, Delphine Sauce, et al.
AIDS (London, England)|May 2, 2012
25 Years of AIDS: recording progress and future challengesJay A Levy, Brigitte Autran, Roel A Coutinho, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 10, 2026
A Response to the Letter to the Editor: "Re: 'Human Immunodeficiency Virus Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in NSCLC'" by Gokhan Koker and OzcelikBaptiste Abbar, Karim Labreche, Marianne Veyri, et al.
Virology|June 22, 2010
Disease progression due to dual infection in an HLA-B57-positive asymptomatic long-term nonprogressor infected with a nef-defective HIV-1 strainMartine Braibant, Jing Xie, Assia Samri, et al.
European Journal of Immunology|October 2, 2002
Differential requirement of caspases during naive T cell proliferationAlexandre Boissonnas, Olivia Bonduelle, Bruno Lucas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 17, 2008
Characteristics of the env genes of HIV type 1 quasispecies in long-term nonprogressors with broadly neutralizing antibodiesMartine Braibant, Henri Agut, Christine Rouzioux, et al.
AIDS (London, England)|March 2, 2011
Long-term nonprogressors and elite controllers in the ANRS CO5 HIV-2 cohortRodolphe Thiébaut, Sophie Matheron, Audrey Taieb, et al.
Medecine Sciences : M/S|May 2, 2020
[Viral reservoir in HIV-2 infection: a model for attenuated retroviral infection]Assia Samri, Charlotte Charpentier, Rémi Cheynier, et al.
Journal of Virology|January 21, 2011
The V1V2 domain and an N-linked glycosylation site in the V3 loop of the HIV-1 envelope glycoprotein modulate neutralization sensitivity to the human broadly neutralizing antibody 2G12Antoine Chaillon, Martine Braibant, Thierry Moreau, et al.
AIDS (London, England)|December 24, 2013
The tyrosine kinase inhibitor Dasatinib blocks in-vitro HIV-1 production by primary CD4+ T cells from HIV-1 infected patientsManuela Pogliaghi, Laura Papagno, Sidonie Lambert, et al.
Pageof 21

Showing results (31-40 of 201) with videos related to

Sort By:
Pageof 21
Experimental Gerontology|February 20, 2007
Accelerated immune senescence and HIV-1 infectionVictor Appay, Jorge R Almeida, Delphine Sauce, et al.
AIDS (London, England)|May 2, 2012
25 Years of AIDS: recording progress and future challengesJay A Levy, Brigitte Autran, Roel A Coutinho, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 10, 2026
A Response to the Letter to the Editor: "Re: 'Human Immunodeficiency Virus Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in NSCLC'" by Gokhan Koker and OzcelikBaptiste Abbar, Karim Labreche, Marianne Veyri, et al.
Virology|June 22, 2010
Disease progression due to dual infection in an HLA-B57-positive asymptomatic long-term nonprogressor infected with a nef-defective HIV-1 strainMartine Braibant, Jing Xie, Assia Samri, et al.
European Journal of Immunology|October 2, 2002
Differential requirement of caspases during naive T cell proliferationAlexandre Boissonnas, Olivia Bonduelle, Bruno Lucas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 17, 2008
Characteristics of the env genes of HIV type 1 quasispecies in long-term nonprogressors with broadly neutralizing antibodiesMartine Braibant, Henri Agut, Christine Rouzioux, et al.
AIDS (London, England)|March 2, 2011
Long-term nonprogressors and elite controllers in the ANRS CO5 HIV-2 cohortRodolphe Thiébaut, Sophie Matheron, Audrey Taieb, et al.
Medecine Sciences : M/S|May 2, 2020
[Viral reservoir in HIV-2 infection: a model for attenuated retroviral infection]Assia Samri, Charlotte Charpentier, Rémi Cheynier, et al.
Journal of Virology|January 21, 2011
The V1V2 domain and an N-linked glycosylation site in the V3 loop of the HIV-1 envelope glycoprotein modulate neutralization sensitivity to the human broadly neutralizing antibody 2G12Antoine Chaillon, Martine Braibant, Thierry Moreau, et al.
AIDS (London, England)|December 24, 2013
The tyrosine kinase inhibitor Dasatinib blocks in-vitro HIV-1 production by primary CD4+ T cells from HIV-1 infected patientsManuela Pogliaghi, Laura Papagno, Sidonie Lambert, et al.
Pageof 21